These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22841818)

  • 1. Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.
    Kassel KM; Sullivan BP; Cui W; Copple BL; Luyendyk JP
    Am J Pathol; 2012 Oct; 181(4):1287-95. PubMed ID: 22841818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.
    Kopec AK; Joshi N; Towery KL; Kassel KM; Sullivan BP; Flick MJ; Luyendyk JP
    J Pharmacol Exp Ther; 2014 Nov; 351(2):288-97. PubMed ID: 25138021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.
    Luyendyk JP; Sullivan BP; Guo GL; Wang R
    Am J Pathol; 2010 Jan; 176(1):177-86. PubMed ID: 20008134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet.
    Kassel KM; Owens AP; Rockwell CE; Sullivan BP; Wang R; Tawfik O; Li G; Guo GL; Mackman N; Luyendyk JP
    Am J Pathol; 2011 Nov; 179(5):2278-89. PubMed ID: 21907177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.
    Wouters K; van Gorp PJ; Bieghs V; Gijbels MJ; Duimel H; Lütjohann D; Kerksiek A; van Kruchten R; Maeda N; Staels B; van Bilsen M; Shiri-Sverdlov R; Hofker MH
    Hepatology; 2008 Aug; 48(2):474-86. PubMed ID: 18666236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
    Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
    Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-HEPE-Concentrated Materials from Pacific Krill Improve Plasma Cholesterol Levels and Hepatic Steatosis in High Cholesterol Diet-Fed Low-Density Lipoprotein (LDL) Receptor-Deficient Mice.
    Saito M; Ishida N; Yamada H; Ibi M; Hirose M
    Biol Pharm Bull; 2020; 43(6):919-924. PubMed ID: 32475913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis.
    Galastri S; Zamara E; Milani S; Novo E; Provenzano A; Delogu W; Vizzutti F; Sutti S; Locatelli I; Navari N; Vivoli E; Caligiuri A; Pinzani M; Albano E; Parola M; Marra F
    Clin Sci (Lond); 2012 Oct; 123(7):459-71. PubMed ID: 22545719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice.
    Rensen SS; Bieghs V; Xanthoulea S; Arfianti E; Bakker JA; Shiri-Sverdlov R; Hofker MH; Greve JW; Buurman WA
    PLoS One; 2012; 7(12):e52411. PubMed ID: 23285030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue.
    Kudo H; Yata Y; Takahara T; Kawai K; Nakayama Y; Kanayama M; Oya T; Morita S; Sasahara M; Mann DA; Sugiyama T
    Liver Int; 2009 Aug; 29(7):988-96. PubMed ID: 19386026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice.
    Tang K; Wang F; Zeng Y; Chen X; Xu X
    Eur J Pharmacol; 2018 Jul; 830():76-86. PubMed ID: 29704496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.
    Cheng K; Song Z; Zhang H; Li S; Wang C; Zhang L; Wang T
    Med Mol Morphol; 2019 Dec; 52(4):187-197. PubMed ID: 30673851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
    Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
    Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    Lytle KA; Jump DB
    PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
    Subramanian S; Goodspeed L; Wang S; Kim J; Zeng L; Ioannou GN; Haigh WG; Yeh MM; Kowdley KV; O'Brien KD; Pennathur S; Chait A
    J Lipid Res; 2011 Sep; 52(9):1626-35. PubMed ID: 21690266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats.
    Chen J; Liu D; Bai Q; Song J; Guan J; Gao J; Liu B; Ma X; Du Y
    Mol Med Rep; 2011; 4(5):811-6. PubMed ID: 21643627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.